WebView today's ONTX stock price, trade commission-free, and discuss ONTX stock updates with the investor community. ... (ONTX) Q4 2024 Earnings Call Transcript. Seeking Alpha • 03/17/23. Onconova Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update. WebEarnings Summary For their last quarter, Onconova Therapeutics (ONTX) reported earnings of -$0.26 per share, missing the Zacks Consensus Estimate of -$0.21 per …
Onconova Therapeutics, Inc. Common Stock (ONTX) Earnings
WebOnconova Therapeutic (ONTX) reports earnings on 3/16/2024. Shares are down 10.1% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for … WebONTX Stock Price - Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, ... The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by … green shirt brown boots
Onconova Therapeutics, Inc. (ONTX) - Yahoo Finance
Web6 de abr. de 2024 · -- Onconova Therapeutics liet donderdag weten dat Chief Medical Officer Mark Gelder onlangs onverwacht is overleden. Het biofarmaceutische bedrijf in de klinische fase zei dat het niet verwacht dat... 12 april 2024 WebUpcoming Earnings - US Historical Earnings - World. United States Canada UK Hong Kong Japan Australia New Zealand. ... ONTX available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest. WebOnconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates. Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue surprises of -23.81% and 5%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? green shirt brown shoes